NCT06563102 - Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

September 11, 2024

Primary Completion Date

February 20, 2026

Study Completion Date

February 20, 2026

Conditions

Mild Asthma

Interventions

COMBINATION_PRODUCT

Albuterol/Budesonide

Oral Inhalation. Rescue medication. Unit dose strength of 80 μg budesonide and 90 μg albuterol per actuation

COMBINATION_PRODUCT

Albuterol

Oral Inhalation. Rescue medication. Unit dose strength of 90μg albuterol per actuation.

Trial Locations (19)

19464

WITHDRAWN

Research Site, Pottstown

27607

WITHDRAWN

Research Site, Raleigh

29420

RECRUITING

Research Site, North Charleston

31904

RECRUITING

Research Site, Columbus

33462

RECRUITING

Research Site, Lake Worth

33613

WITHDRAWN

Research Site, Tampa

33990

RECRUITING

Research Site, Cape Coral

46168

RECRUITING

Research Site, Plainfield

63141

RECRUITING

Research Site, St Louis

73120

RECRUITING

Research Site, Oklahoma City

76712

RECRUITING

Research Site, Waco

77030

RECRUITING

Research Site, Houston

79903

RECRUITING

Research Site, El Paso

83706

RECRUITING

Research Site, Boise

85040

TERMINATED

Research Site, Phoenix

85715

RECRUITING

Research Site, Tucson

92123

RECRUITING

Research Site, San Diego

93534

RECRUITING

Research Site, Lancaster

07457

RECRUITING

Research Site, Riverdale